These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9751446)

  • 61. Involvement of ETA receptors in the facilitation by endothelin-1 of non-adrenergic non-cholinergic transmission in the rat urinary bladder.
    Donoso MV; Salas C; Sepúlveda G; Lewin J; Fournier A; Huidobro-Toro JP
    Br J Pharmacol; 1994 Feb; 111(2):473-82. PubMed ID: 8004392
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differences between endothelin receptors mediating contraction of guinea-pig aorta and pig coronary artery.
    Schoeffter P; Randriantsoa A
    Eur J Pharmacol; 1993 Nov; 249(2):199-206. PubMed ID: 8287901
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouse.
    Mizuguchi T; Nishiyama M; Moroi K; Tanaka H; Saito T; Masuda Y; Masaki T; de Wit D; Yanagisawa M; Kimura S
    Br J Pharmacol; 1997 Apr; 120(8):1427-30. PubMed ID: 9113361
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differential effects of BQ-123 against endothelin-1 and endothelin-3 on the rat vas deferens: evidence for an atypical endothelin receptor.
    Eglezos A; Cucchi P; Patacchini R; Quartara L; Maggi CA; Mizrahi J
    Br J Pharmacol; 1993 Jul; 109(3):736-8. PubMed ID: 8358569
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Solution structure of a novel ETB receptor selective agonist ET1-21 [Cys(Acm)1,15, Aib3,11, Leu7] by nuclear magnetic resonance spectroscopy and molecular modelling.
    Hewage CM; Jiang L; Parkinson JA; Ramage R; Sadler IH
    J Pept Res; 1999 Mar; 53(3):223-33. PubMed ID: 10231710
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Structure-activity relationships of cyclic pentapeptide endothelin A receptor antagonists.
    Fukami T; Nagase T; Fujita K; Hayama T; Niiyama K; Mase T; Nakajima S; Fukuroda T; Saeki T; Nishikibe M
    J Med Chem; 1995 Oct; 38(21):4309-24. PubMed ID: 7473559
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synthesis, molecular modelling, and NMR structure determination of four cyclic peptide antagonists of endothelin.
    Bradley EK; Ng SC; Simon RJ; Spellmeyer DC
    Bioorg Med Chem; 1994 Apr; 2(4):279-96. PubMed ID: 7922139
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evidence for atypical endothelin receptors and for presence of endothelin-converting enzyme activity in the mouse isolated vas deferens.
    Mass J; D'Orléans-Juste P; Yano M; Rae GA
    Eur J Pharmacol; 1995 Mar; 276(1-2):113-21. PubMed ID: 7781681
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The crystal structure of human endothelin.
    Janes RW; Peapus DH; Wallace BA
    Nat Struct Biol; 1994 May; 1(5):311-9. PubMed ID: 7664037
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The solution structure of sarafotoxin-c. Implications for ligand recognition by endothelin receptors.
    Mills RG; Ralston GB; King GF
    J Biol Chem; 1994 Sep; 269(38):23413-9. PubMed ID: 8089105
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A linear endothelin-1 analogue: solution structure of ET-1[Aib1,3,11,15, Nle7] by nuclear magnetic resonance spectroscopy and molecular modelling.
    Hewage CM; Jiang L; Parkinson JA; Ramage R; Sadler IH
    Neurochem Int; 1999 Jul; 35(1):35-45. PubMed ID: 10403428
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synthesis and structure-activity relationship studies of new endothelin pseudopeptide analogues containing alkyl spacers.
    Galoppini C; Giusti L; Macchia M; Hamdan M; Mazzoni MR; Calvani F; Rovero P
    Farmaco; 1999 Apr; 54(4):213-7. PubMed ID: 10384713
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Solution conformation of endothelin and point mutants by nuclear magnetic resonance spectroscopy.
    Dalgarno DC; Slater L; Chackalamannil S; Senior MM
    Int J Pept Protein Res; 1992 Dec; 40(6):515-23. PubMed ID: 1286935
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Proposed solution structure of endothelin.
    Perkins TD; Hider RC; Barlow DJ
    Int J Pept Protein Res; 1990 Aug; 36(2):128-33. PubMed ID: 2272749
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.
    Hay DW; Luttmann MA; Beck G; Ohlstein EH
    Br J Pharmacol; 1996 Jul; 118(5):1209-17. PubMed ID: 8818345
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi.
    Fukuroda T; Ozaki S; Ihara M; Ishikawa K; Yano M; Miyauchi T; Ishikawa S; Onizuka M; Goto K; Nishikibe M
    Br J Pharmacol; 1996 Mar; 117(6):995-9. PubMed ID: 8882588
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Endothelin receptor subtypes in human and guinea-pig pulmonary tissues.
    Hay DW; Luttmann MA; Hubbard WC; Undem BJ
    Br J Pharmacol; 1993 Nov; 110(3):1175-83. PubMed ID: 8298806
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
    Warner TD; Allcock GH; Corder R; Vane JR
    Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Solution-structure of a peptide designed to mimic the C-terminal hexapeptide of endothelin.
    Van der Walle CF; Bansal S; Barlow DJ
    J Pharm Pharmacol; 1998 Aug; 50(8):837-44. PubMed ID: 9751446
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.